HghStudy Information Site Home | Definitions | Bookmark | Site Map


About HGH

Human Growth Hormone
What is Human Growth Hormone
HGH Hormone
History of HGH

Benefits

HGH Anti Aging
HGH Benefits

Products

HGH Products
HGH Injections
Genotropin
Humatrope
Norditropin
Nutropin
Omnitrope
Saizen
Serostim
Ultimate HGH

Oral Spray hGH
FTC Stops False Claims


Side Effects

Side Effects of HGH
Prescription HGH

HGH Treatment

HGH Therapy

Endocrinology

What is Endocrinology?
Endocrine System
Endocrine Diseases

Miscellaneous

Myths & Facts About HGH
HGH Publications
Licit Uses of HGH
Illicit Uses of HGH
Illicit Distribution of HGH

Copyright &
Disclaimer Info
© HGHStudy.com
2004/2008

Gerstmann-Straussler-Scheinker Disease (GSS)

What is Gerstmann-Straussler-Scheinker Disease (GSS)?
Gerstmann-Straussler-Scheinker (GSS) disease is an extremely rare, neurodegenerative brain disorder. It is almost always inherited and is found in only a few families around the world.

Onset of the disease usually occurs between the ages of 35 and 55. In the early stages, patients may experience varying levels of ataxia (lack of muscle coordination), including clumsiness, unsteadiness, and difficulty walking. As the disease progresses, the ataxia becomes more pronounced and most patients develop dementia.

Other symptoms may include dysarthria (slurring of speech), nystagmus (involuntary movements of the eyes), spasticity (rigid muscle tone), and visual disturbances, sometimes leading to blindness. Deafness also can occur. In some families, parkinsonian features are present.

GSS belongs to a family of human and animal diseases known as the Transmissible Spongiform Encephalopathies (TSEs). Other TSEs include Creutzfeldt-Jakob Disease (CJD), Kuru, and Fatal Familial Insomnia (FFI).

Is There Any Treatment?
There is no cure for GSS, nor are there any known treatments to slow progression of the disease. Current therapies are aimed at alleviating symptoms and making the patient as comfortable as possible.

What is the Prognosis?
GSS is a slowly progressive condition usually lasting from 2 to 10 years. The disease ultimately causes severe disability and finally death, often after the patient goes into a coma or has a secondary infection such as aspiration pneumonia due to an impaired ability to swallow.

What Research is Being Done?
The National Institute of Neurological Disorders and Stroke (NINDS) supports and conducts research on TSEs, including GSS. Much of this research is aimed at characterizing the agents that cause these disorders, clarifying the mechanisms underlying them, and, ultimately, finding ways to prevent, treat, and cure them.

Organizations

National Organization for Rare Disorders (NORD)
P.O. Box 1968 (55 Kenosia Avenue)
Danbury, CT 06813-1968
orphan@rarediseases.org
http://www.rarediseases.org
Tel: 203-744-0100
Voice Mail 800-999-NORD (6673)
Fax: 203-798-2291

National Institute on Aging (NIA)
National Institutes of Health, DHHS
31 Center Drive, Rm. 5C27 MSC 2292
Bethesda, MD 20892-2292
http://www.nia.nih.gov
Tel: 301-496-1752
800-222-2225
TTY: 800-222-4225

References:
February 2007
www.ninds.nih.gov/disorders/gss/gss.htm

More Info

Human Growth Foundation
Pituitary Society
Pituitary Network Association
Important:
Health Alert


Partners

Heartburn
Acne Medication
Hair Removal

Sponsors

HGHStudy Supporters
Home | Definitions | Bookmark | Site Map
© HGHStudy.com
2004/2008
All information on HGHStudy is for educational purposes only.
For specific medical advice, diagnoses, and treatment, consult your doctor.